HC Deb 16 November 1976 vol 919 c493W
Mr. Adley

asked the Secretary of State for Social Services what is his policy towards the availability on NHS prescription of Naudicelle tablets for those suffering from multiple sclerosis; and if he will make a statement.

Mr. Moyle

Independent medical experts have advised that the evidence is insufficient to justify regarding linoleic acid, the basic ingredient of Naudicelle capsules, as having a therapeutic effect on multiple sclerosis. Linoleic acid, its compounds and derivatives, therefore, cannot be regarded as medicines that may be supplied at health services expense to multiple sclerosis patients who are living at home and being treated by a family doctor.

Naturally I understand the hon. Member's interest in this subject. I am writing to him setting out the full position and copies of my letter will be placed in the Library.